These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2781139)

  • 21. Vasodilator action of KB-944, a new calcium antagonist.
    Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of alpha-1 and alpha-2 adrenoceptors in modulation of coronary flow during exercise.
    Strader JR; Gwirtz PA; Jones CE
    J Pharmacol Exp Ther; 1988 Aug; 246(2):772-8. PubMed ID: 2900330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the pharmacology of the alpha-receptor blocker BE 2254 (HEAT) (author's transl)].
    Heinz N; Hofferber E
    Arzneimittelforschung; 1980; 30(12):2135-9. PubMed ID: 6111325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central action of prostaglandin F2alpha on circulatory system in rats.
    Brus R; Zabawska J
    Pol J Pharmacol Pharm; 1976; 28(5):455-62. PubMed ID: 1012975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
    Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstriction in the in situ, autoperfused, pulmonary circulation of the anesthetized dog.
    Shebuski RJ; Fujita T; Ruffolo RR
    J Pharmacol Exp Ther; 1986 Jul; 238(1):217-23. PubMed ID: 3014116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The action of propranolol on the dog heart.
    Harry JD; Linden RJ; Snow HM
    Br J Pharmacol; 1972 May; 45(1):155P-156P. PubMed ID: 4402822
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiovascular pharmacology of ASL-7022, a novel catecholamine. I. Inotropic, chronotropic and pressor actions.
    Gorczynski RJ
    J Pharmacol Exp Ther; 1982 Oct; 223(1):7-11. PubMed ID: 7120130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
    Privitera PJ; Granata AR; Underwood MD; Gaffney TE; Reis DJ
    J Pharmacol Exp Ther; 1988 Aug; 246(2):529-33. PubMed ID: 3404445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Undifferentiated effects of calcium antagonists on pressor responses to selective alpha-1 and alpha-2 adrenoceptor agonists in anesthetized, spinal dogs.
    Morita T; Maniwa T; Satoh K; Taira N
    J Pharmacol Exp Ther; 1985 Sep; 234(3):728-34. PubMed ID: 2863372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
    Hahn RA; MacDonald BR
    J Pharmacol Exp Ther; 1984 Sep; 230(3):558-68. PubMed ID: 6470973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some cardiovascular effects of cyclocytidine.
    Herman EH; Chadwick DP
    Cancer Treat Rep; 1976 Nov; 60(11):1663-6. PubMed ID: 66094
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparison of the effects of bepridil, dipyridamole, and propranolol on the cardiac activity and the coronary venous debt in anesthetized dogs].
    Michelin MT; Cheucle M; Duchene-Marullaz P
    Therapie; 1977; 32(4):485-99. PubMed ID: 605426
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular effects of reserpine, yohimbine, and reserpine-yohimbine mixtures on intact anesthetized dog.
    Luckens MM; Malone MH
    J Pharm Sci; 1973 Aug; 62(8):1286-90. PubMed ID: 4725172
    [No Abstract]   [Full Text] [Related]  

  • 37. Baroreflex and vagal mechanisms modulating left ventricular contractile responses to sympathomimetic amines in conscious dogs.
    Vatner SF; Rutherford JD; Ochs HR
    Circ Res; 1979 Feb; 44(2):195-207. PubMed ID: 761303
    [No Abstract]   [Full Text] [Related]  

  • 38. [Synthesis and cardiovascular activities of peptidyl dopamine derivatives].
    Gao DM; Yang FQ; Chen GL; Cheng WY; Chen JC; Min Y; Shang HM; Zhang SA
    Yao Xue Xue Bao; 1989; 24(6):422-30. PubMed ID: 2609981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of prazosin on cardiac reflex function.
    Hardey DW; Lokhandwala MF
    Eur J Pharmacol; 1979 Aug; 57(2-3):251-4. PubMed ID: 488164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Aralkyl substitution of 2-amino-5,6- and -6,7-dihydroxy-1,2,3,4-tetrahydronaphthalenes. 1. Cardiac and pressor/depressor activities.
    Gorczynski RJ; Anderson WG; Stout DM
    J Med Chem; 1981 Jul; 24(7):835-9. PubMed ID: 7277389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.